Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late phase II trial of KDT-3594 with levodopa in advanced Parkinson's disease
jRCT2051240199Phase 2Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing KDT-3594 add-on with Placebo add-on (2 arms). Started Dec 2024; status: completed.
02
Drugs
matsupexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2051240199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051240199.